Hesai Group (HSAI)
Sous-évaluéFondamental
45
Prix
$15.84
Capitalisation boursière
$20.05B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Hesai Group, through with its subsidiaries, engages in the development, manufacturing, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally. The company provides gas sensor products, validation services, solution service, and other services, as well as designs and develops engineering products. Its LiDAR products are used in passenger and commercial vehicles with advanced driver assistance systems; autonomous vehicle fleets providing passenger and freight mobility services; and other applications, such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas. Hesai Group was founded in 2014 and is headquartered in Shanghai, China.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 septembre 2026 with claude-haiku-4-5 — shared with all users
RoboSense is Hesai's closest rival for the same design wins at Chinese carmakers, selling lidar for driver-assistance systems and, increasingly, for robots and robotaxis.
Huawei supplies its own automotive lidar bundled with its driving software and compute, competing with Hesai for sensor slots on Chinese vehicle programs.
Seyond sells long-range automotive lidar to the same Chinese and international carmakers, having built its position as Nio's main supplier.
Valeo's Scala lidar competes for the same driver-assistance sensor contracts, especially with European carmakers where Hesai is trying to expand.
Luminar targets the same long-range automotive lidar market with Western carmakers, the segment Hesai is pushing into outside China.
Ouster competes with Hesai's non-automotive line, selling lidar to robotics, industrial and smart-infrastructure customers.
Bilan & Liquidités
Chiffre d'affaires
$3.34B
12 derniers mois (au 30/06/2026)
Résultat net
$498M
12 derniers mois (au 30/06/2026)
Flux de trésorerie libre
$-328M
Capitaux propres totaux
$8.86B
Passif total
$706M
Ratio de liquidité général
5.37
Couverture des intérêts
-
Dette/EBITDA
7.80
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$25.09
Prix actuel
$15.84
Marge de sécurité
+36.9%
Fourchette de juste valeur
$18.13 - $32.05
Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
31.90
ROE
7.5%
Ratio P/B
1.88
P/FCF
-
Marge brute
40.7%
ROIC
0.1%
Radar de rentabilité
Création de valeur (avantage concurrentiel)
ROIC
0.1%
WACC
9.3%
ROIC − WACC
-9.2 pp
Le ROIC est inférieur au coût du capital — l'entreprise détruit de la valeur pour chaque dollar investi.
Critères d'analyse fondamentale
Réussi (9)
- Price CAGR 22.32%
- Gross Margin 40.7%
- P/B Ratio 1.88
- Debt/Equity ratio
- Current Ratio
- Revenue Growth 5Y 54.1%
- Analyst Consensus 97% Buy
- Earnings Surprise avg 79.4%
- Net Margin Trend 14.4% vs -4.9%
Échoué (7)
- ROIC 0.1%
- Positive Free Cash Flow
- Debt/EBITDA
- DCF valuation (Unknown)
- ROE 5.6%
- Earnings Quality (OCF/NI) 0.64
- Piotroski F-Score 1/9
Indisponible (11)
- EPS data insufficient
- P/FCF NaN
- Dividend Payout NaN%
- Operating Margin NaN%
- CapEx intensity
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- PEG Ratio (need PE > 0 and growth > 0)
- Share Dilution (missing shares data)
Score F de Piotroski
Préoccupations financières sérieuses
Qualité des bénéfices
Modérée : certain écart entre profits et trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Participations institutionnelles
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Dr. Yifan Li | Co-Founder, Chairman of the Board & CEO | 38 |
| Dr. Kai Sun | Co-Founder, Chief Scientist & Executive Director | 39 |
| Mr. Shaoqing Xiang | Co-Founder, CTO & Executive Director | 39 |
| Mr. Peng Fan | Chief Financial Officer | 42 |
| Ms. Cailian Yang | VP of Operations, Executive Director & Joint Company Secretary | 34 |
| Yuanting Shi | Head of Capital Markets | - |
| Ms. Au Yeung | Joint Company Secretary | 36 |
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for HSAI, sourced from Markets Gazette.
- 5/20/2026POSITIVEHesai CEO Li on Earnings, Mercedes-Benz Deal
Hesai Group, a leading Chinese lidar manufacturer, has secured a significant partnership with Mercedes-Benz, which will integrate Hesai's sensors across multiple vehicle models moving into production. CEO David Li highlighted this as a key milestone, signaling strong demand and validation for the company's technology. Furthermore, Li noted increasing adoption in emerging sectors like humanoid robotics, pointing to substantial long-term growth potential. Investors view this development positively, as it not only expands Hesai's automotive footprint but also diversifies its market reach into high-growth technology areas, potentially leading to increased revenue and market share.
- 3/24/2026NEGATIVEHesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Hesai Group (HSAI) saw its shares decline by 6.6% in pre-market trading following the release of its quarterly financial results. The company reported lower-than-expected earnings and sales, signaling potential headwinds in its operational performance. This downturn in pre-market activity for HSAI, alongside a broader dip in Dow futures by 0.2%, suggests a cautious sentiment among investors. The disappointing financial figures may lead to downward revisions in analyst price targets and could impact investor confidence in the company's near-term growth prospects.
via Markets Gazette